# A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

> **NCT04195373** · PHASE1 · WITHDRAWN · sponsor: **Themis Bioscience GmbH**

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **BIOLOGICAL:** TMV-018 + 5-FC
- **BIOLOGICAL:** TMV-018 + anti-PD-1
- **BIOLOGICAL:** TMV-018 + 5-FC + anti-PD-1

## Key facts

- **NCT ID:** NCT04195373
- **Lead sponsor:** Themis Bioscience GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11-23
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not started, no subjects recruited.
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195373, "A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04195373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*